Ad is loading...
MENU

BCAB BioAtla Forecast, Technical & Fundamental Analysis

Industry Biotechnology
BCAB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
BCAB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BCAB is expected to report earnings to rise 66.68% to -36 cents per share on March 20

BioAtla BCAB Stock Earnings Reports
Q4'24
Est.
$-0.37
Q3'24
Beat
by $0.19
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.06
Q4'23
Beat
by $0.23
The last earnings report on November 07 showed earnings per share of -21 cents, beating the estimate of -40 cents. With 1.73M shares outstanding, the current market capitalization sits at 75.42M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11085 Torreyana Road
Phone
+1 858 558-0708
Employees
65
Web
https://www.bioatla.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GMED81.10N/A
N/A
Globus Medical
CSCO57.46-0.46
-0.79%
Cisco Systems
JELD10.19-0.17
-1.64%
JELD-WEN Holding
SCOR7.28-0.60
-7.61%
comScore
FHTX8.01-0.79
-8.98%
Foghorn Therapeutics

BCAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been loosely correlated with AXON. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
-8.77%
AXON - BCAB
41%
Loosely correlated
-0.86%
DNLI - BCAB
40%
Loosely correlated
-11.95%
CTMX - BCAB
39%
Loosely correlated
-9.00%
VCYT - BCAB
38%
Loosely correlated
-2.97%
CYTK - BCAB
38%
Loosely correlated
-8.19%
More